alanine, 3-(3,4-dihydroxyphenyl)-, L-

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 21 USDMF, 12 CEP/COS, 4 JDMF, 3 EU WC, 9 KDMF, 12 NDC API, 17 Listed Suppliers

DEVELOPMENTS

71 Drugs in Development

71 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

945 FDF Dossiers, 147 FDA Orange Book, 611 Europe, 34 Canada, 88 Australia, 14 South Africa, 51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG;100MG, TABLET;ORAL - 25MG;100MG, TABLET;ORAL - 25MG;250MG, TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG, CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG, CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG, CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG, TABLET;ORAL - 12.5MG;200MG;50MG, TABLET;ORAL - 18.75MG;200MG;75MG, TABLET;ORAL - 25MG;200MG;100MG, TABLET;ORAL - 31.25MG;200MG;125MG, TABLET;ORAL - 37.5MG;200MG;150MG, TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 4 Evonik, 4 Rochem International Inc, 21 SPI Pharma, 8 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 4 Kirsch Pharma, 1 Panvo Organics, 2 Cerata Pharmaceuticals LLP, 4 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 29 BASF, 1 CD Formulation, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 1 Finar, 12 Gangwal Chemicals, 2 Gloria Interchem, 9 Ideal Cures, 5 Ingredion Pharma Solutions, 22 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

79 Fillers, Diluents & Binders, 57 Coating Systems & Additives, 45 Disintegrants & Superdisintegrants, 37 Direct Compression, 35 Solubilizers, 34 Thickeners and Stabilizers, 34 Granulation, 33 Controlled & Modified Release, 27 Taste Masking, 24 Parenteral, 23 Chewable & Orodispersible Aids, 23 Lubricants & Glidants, 22 Film Formers & Plasticizers, 16 Co-Processed Excipients, 15 Topical, 11 API Stability Enhancers, 8 Emulsifying Agents, 6 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 107 News #PharmaBuzz

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 69 Regulatory FDF Prices, 27 Annual Reports

MARKET PLACE

24 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

315 US Patents, 4 US Exclusivities, 9 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 8 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Alanine, 3-(3,4-dihydroxyphenyl)-, L-

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Seppic

filter Capability Reset all filters

filter Country Reset all filters

01

Seppic

SEPIFILM CLASSIC RANGE

Stanford Drug Discovery Symposium

Not Confirmed

02

Seppic

SEPIFILM PW RANGE

Stanford Drug Discovery Symposium

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for alanine, 3-(3,4-dihydroxyphenyl)-, L-? Find Coloring Agents used in alanine, 3-(3,4-dihydroxyphenyl)-, L- to address drug delivery challenges on PharmaCompass.

alanine, 3-(3,4-dihydroxyphenyl)-, L-

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers

21 USDMF

12 CEP/COS

4 JDMF

3 EU WC

9 KDMF

12 NDC API

17 Listed Suppliers

DEVELOPMENTS

71 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

945 FDF Dossiers

147 FDA Orange Book

611 Europe

34 Canada

88 Australia

14 South Africa

51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG;100MG

TABLET;ORAL - 25MG;100MG

TABLET;ORAL - 25MG;250MG

TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG

CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG

CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG

CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG

TABLET;ORAL - 12.5MG;200MG;50MG

TABLET;ORAL - 18.75MG;200MG;75MG

TABLET;ORAL - 25MG;200MG;100MG

TABLET;ORAL - 31.25MG;200MG;125MG

TABLET;ORAL - 37.5MG;200MG;150MG

TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

4 Evonik

4 Rochem International Inc

21 SPI Pharma

8 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

1 Capital Farma

4 Kirsch Pharma

1 Panvo Organics

2 Cerata Pharmaceuticals LLP

4 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

8 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

29 BASF

1 CD Formulation

12 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

1 Finar

12 Gangwal Chemicals

2 Gloria Interchem

9 Ideal Cures

5 Ingredion Pharma Solutions

22 Kerry

4 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

17 Microlex e.U

1 Nanjing Bold Chemical

TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons